
所有图片(1/1)
产品介绍 评论(0)
产品规格
宿主来源
Human抗原名称
IL-17A分子别名
Interleukin-17A, Cytotoxic T-lymphocyte-associated antigen 8 (CTLA-8), CTLA8, IL17Accession
Q16552克隆号
S-SC008抗体类型
Recombinant mAb抗体同种型
IgG4,k纯化方式
Protein A浓度
2 mg/ml内毒素含量
<1EU/mg标记
Unconjugated性状
Liquid缓冲体系
PBS pH7.4, containing no preservative
储存条件
12 months from date of receipt / reconstitution, 2 to 8 °C as supplied
应用
Blocking of IL-17A signaling Functional assays
稀释度
应用 稀释度 ELISA 1.221-5000 ng/ml
背景介绍
Ixekizumab is an injectable medication for the treatment of autoimmune diseases. It is a form of a humanized monoclonal antibody. The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation.
ELISA
Immobilized Human IL-17A, His tag(S0A4023) can bind Ixekizumab. The EC50 for this effect is 6.581 ng/mL.







评论(0)